�ڽ��Ƶ_�ڽ��Ƶ_�ڽ��ɫ��Ƭ

UNLEASHING THE PROMISE OF T-CELL THERAPIES.

DISCOVER ATARA

Cutting-edge science. A fresh approach.

�ڽ��Ƶ is an allogeneic T-cell immunotherapy company. We're harnessing the natural biology of T cells—our body’s most effective weapon in fighting disease—to develop transformative therapies for patients with cancer and autoimmune conditions.

Off-the-shelf approach

Allogeneic T-cell therapies can be readily available for rapid delivery within days.

Scalable manufacturing

Efficient, robust process with the ability to produce over a thousand doses from one healthy donor.

Highly versatile platform

Potential application for a wide range of disease-causing viral and non-viral targets.

OUR TECHNOLOGY

We’re developing a pipeline of firsts.

Our investigational T-cell therapies target difficult-to-treat Epstein-Barr virus (EBV)-driven conditions, including certain cancers and multiple sclerosis, as well as a wide range of non-EBV-associated diseases. We’re the first company ever to receive an approval for an allogeneic T-cell immunotherapy.

Our Pipeline